Alterations in bile acid synthesis in carriers of hepatocyte nuclear factor 1α mutations

Unknown

(2011) Maria Galan et al.   MOLECULAR MEDICINE

Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels

(2010) JWA van der Hoorn et al.   BRITISH JOURNAL OF PHARMACOLOGY

Maturity-onset diabetes of the young (MODY): how many cases are we missing?

(2010) B. M. Shields et al.   DIABETOLOGIA

Control of ACAT2 Liver Expression by HNF4α

(2009) C. Pramfalk et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dyslipidemia in type 2 diabetes mellitus

(2009) Arshag D Mooradian   Nature Reviews Endocrinology

Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression

(2008) Kwang-Hoon Song et al.   HEPATOLOGY